Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is... Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 5.33 | 28.5331905782 | 18.68 | 25.26 | 18.25 | 508915 | 22.03869875 | CS |
| 4 | 5.23 | 27.8487752929 | 18.78 | 25.26 | 18.25 | 250751 | 20.95530989 | CS |
| 12 | 5.79 | 31.7782656422 | 18.22 | 25.26 | 14.72 | 255584 | 19.20078231 | CS |
| 26 | 23.9728 | 64443.0107527 | 0.0372 | 25.26 | 0.0372 | 266146 | 19.22941781 | CS |
| 52 | 23.9728 | 64443.0107527 | 0.0372 | 25.26 | 0.0372 | 131482 | 19.22941781 | CS |
| 156 | 20.78 | 643.343653251 | 3.23 | 25.26 | 0.033 | 3905979 | 0.40455667 | CS |
| 260 | 13.48 | 128.015194682 | 10.53 | 25.26 | 0.033 | 2550279 | 0.8078876 | CS |
User-860044
1年前
hondaboost
2年前
Fredric
2年前
Fredric
2年前
shurtha2000
2年前
shurtha2000
2年前
shurtha2000
2年前
shurtha2000
2年前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。